Friday, June 19, 2026

pharma · Migraine · Narcolepsy

H. Lundbeck A/S

H. Lundbeck A/S trial registry — 17 ClinicalTrials.gov studies with program phase, status, and indication context.

Postboks 361, LYSAKER, Bærum 1326, NO, Valby, CN HQ
112 Employees
NMPA registrant Type
Company details
Status
Public
HQ
Postboks 361, LYSAKER, Bærum 1326, NO, Valby, CN
Employees
112
Programs
17
Drugs
14
Patents
0
Intelligence · Clinical Trials

H. Lundbeck A/S clinical trials

Registry index of 17 ClinicalTrials.gov studies linked to H. Lundbeck A/S programs — each row shows trial ID, program name, phase, status, and indication.

H. Lundbeck A/S trial registry — 17 ClinicalTrials.gov studies with program phase, status, and indication context.

Recent trial activity

8 updates

Latest clinical program signals indexed for H. Lundbeck A/S.

  1. 21117A — Phase 1

    Clinical update
  2. 20653A — Phase 1

    Clinical update
  3. 19356A — Phase 3

    Clinical update
  4. 20453A — Phase 1

    Clinical update
  5. 20433A — Phase 2

    Clinical update
  6. 20432A — Phase 3

    Clinical update
  7. Lu AF28996 — Phase 1

    Clinical update
  8. Eptinezumab — Phase 3

    Clinical update

Trial registry

17 studies